Clinical Trials at Memorial Sloan Kettering Monmouth (All Protocol Activities)
As of July 2026, 54 paid clinical trials are recruiting at Memorial Sloan Kettering Monmouth (All Protocol Activities), located at 480 RED HILL RD, MIDDLETOWN, NJ 07748-3052, phone (212) 639-2000 in Middletown, New Jersey. Active studies at this site cover conditions such as Breast Cancer, Multiple Myeloma and Acute Myeloid Leukemia. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Newly added in Middletown
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
A Study of CRD3874-SI in People With Leukemia
A Study of a Side Effects and Resource Navigation Program for People With Cancer
A Study of Tepotinib and Ivonescimab in People With Non-Small Cell Lung Cancer
A Study of Ivonescimab in People With Non-Small Cell Lung Cancer
59 clinical trials at Memorial Sloan Kettering Monmouth (All Protocol Activities)
·Clear filters·↓ Download CSVA Dietary Study for People With Clonal Hematopoiesis
A Study of Ivonescimab in Combination With Dato-DXd or Osimertinib in People With Non-Small Cell Lung Cancer
A Study of BMS-986504 With Standard-of-Care Therapy for People With Solid Tumor Cancer
A Study of Ivonescimab, Chemotherapy, and Stereotactic Radiosurgery for People With Non-Small Cell Lung Cancer
Study of a Support Program for Quality of Life in Chinese Cancer Patients and Survivors
A Study of Elranatamab and Cyclophosphamide in People With Multiple Myeloma
Registry for Bone Metastases
Using a Blood Test and Software Tool to Guide Treatment for Venous Thromboembolism
A Study of Revumenib and Mezigdomide in People With Leukemia
A Study Testing Topical Pain-Relieving Herbal Plasters in People Who Are Using Opioids for Their Pain
Registry Study of People Who Are Having an Esophagectomy and Are at High Risk of Anastomotic Leak
ctDNA Testing to Inform Standard-of-Care Treatment Decisions in People With Endometrial Cancer
A Study of Isoquercetin in People With Ovarian Cancer
Factors Associated With Breast Cancer Risks and Outcomes
Using E-Nose Technology to Track Treatment Response in People With Non-Small Cell Lung Cancer
A Study of Herbal Supplements in Cancer Survivors With Constipation
A Music Therapy Study for Blood Cancer Survivors With Cognitive Difficulties
A Study of Blood Based Biomarkers for Pancreas Adenocarcinoma
A Study of Lorlatinib in Combination With Ramucirumab in People With Lung Cancer
Radiation and TSR-042 (Dostarlimab) in People With Endometrial Cancer After They Receive Surgery
A Study of Fianlimab, Cemiplimab, and Ipilimumab in People With Melanoma
Glioma Developmental and HyperActive Ras Tumor (DHART) Board
A Study of Short-Course Radiation Therapy With Chemotherapy in People With Endometrial Cancer
A Study of Stereotactic Radiosurgery (SRS) and Standard Treatment in People With Lung Cancer That Has Spread to the Brain
A Registry for People With T-cell Lymphoma
A Study of Targeted Radiation Therapy in People With Non-Small Cell Lung Cancer (NSCLC)
A Study of Abemaciclib and Radiation Therapy in People With Metastatic Breast Cancer
A Study of SDX-7320 in Combination With Eribulin for People With Breast Cancer
Study Assessing the Effects of Early Psychiatric Referral on Mental Health and Quality of Life in People With Sarcoma
A Study of Changes in Thinking Related to Aging and Cancer in Breast Cancer Survivors (TRAC)
A Study of Reduced-dose Radiation in People With Metastatic Tumors With a Genetic Change
Enhanced Pain Coping in Cancer (EPIC): A Study of Managing Treatment-Related Joint Pain in Breast Cancer Survivors
A Study of BV-AVD in People With Bulky Hodgkin Lymphoma
Study of Ruxolitinib in Relapsed or Refractory T or NK Cell Lymphoma
A Study of 68Gallium PSMA-PET/CT Scans in People With Bladder Cancer or Skin Cancer
Acupuncture for People Experiencing Period Loss Due to Chemotherapy
Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease
A Study Comparing a Plant-Based Diet With Supplements and Placebo in People With Monoclonal Gammopathy of Undetermined Significance (MGUS) or Smoldering Multiple Myeloma (SMM)
Study of Radiotherapy and Pembrolizumab in People With Adrenocortical Carcinoma
A Study of Ivonescimab in People With Endometrial and Cervical Cancers
About research studies in Middletown
Middletown has approximately 315 recruiting research studies across a wide range of therapeutic areas. New Jersey hosts a diverse network of universities, academic medical centers, and community hospitals that run clinical trials across oncology, cardiology, neurology, and many other therapeutic areas.
Common conditions studied in Middletown
- Breast Cancer (27 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
- Multiple Myeloma (13 active studies). Recruiting Multiple Myeloma studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Acute Myeloid Leukemia (12 active studies). Leukemia trials evaluate targeted inhibitors, CAR-T cell therapies, and novel combinations for acute and chronic forms of the disease.
- Non-Small Cell Lung Cancer (10 active studies). Lung cancer research focuses on targeted therapies for specific mutations such as EGFR, ALK, and KRAS, alongside immunotherapy regimens.
- Metastatic Breast Cancer (9 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
- Prostate Cancer (9 active studies). Prostate cancer studies test next-generation hormone therapies, PARP inhibitors, and radioligand treatments for both localized and advanced disease.
Leading research sponsors in Middletown
- Memorial Sloan Kettering Cancer Center
- National Cancer Institute (NCI)
- NRG Oncology
- Alliance for Clinical Trials in Oncology
- Pfizer
Local regulations and guidelines
Clinical trials in New Jersey are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. New Jersey research additionally follows state public health department oversight and any applicable state privacy statutes.
Compensation & what to expect
- How payment typically works
- Compensation is most often provided through reloadable electronic study cards or direct deposit, paid out per completed visit rather than as a lump sum. Amounts vary by the time required, the number of visits, and the study's complexity — overnight stays and inpatient pharmacology studies generally pay more than short outpatient surveys. The exact amount is disclosed in writing during informed consent before any visit.
- Healthy volunteers
- Healthy participants aged 18 and older can earn compensation by joining vaccine, pharmacology, and biomarker studies in Middletown. These trials check how a new drug or vaccine behaves in healthy bodies before later-phase testing. Many sites maintain a healthy-volunteer registry so you hear about new opportunities first.
- What's included beyond payment
- Most trials cover study-related medical care at no cost — physical exams, lab work, imaging, the investigational treatment itself, and follow-up visits with the research team. Insurance is not required to participate. Free check-ups and access to specialists are common reasons participants return for additional studies.
- Travel and time
- Many sponsors reimburse travel, parking, mileage, and lost wages for visit days. Long-running studies and trials that require frequent visits often raise stipends accordingly. Ask the study coordinator for the visit schedule and reimbursement policy before you commit.
- Asking about compensation
- Compensation is set per protocol and per site, so figures are not published in trial registries. The fastest way to confirm payment for a specific study is to contact the recruiting site listed on the study record. Coordinators are accustomed to this question and will quote the per-visit and total amounts up front.
How to find a clinical trial in Middletown
Hipa.ai aggregates every recruiting study in Middletown from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
Frequently asked questions
How many paid clinical trials are currently recruiting in Middletown?
There are approximately 315 recruiting clinical trials in Middletown, New Jersey listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Middletown pay participants?
Most recruiting trials in Middletown compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Middletown?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Middletown?
The most common conditions under active study in Middletown include Breast Cancer (27), Multiple Myeloma (13), Acute Myeloid Leukemia (12), Non-Small Cell Lung Cancer (10), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Middletown?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Middletown on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Middletown?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Middletown?
Recruiting research sites in Middletown include Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Memorial Sloan Kettering Monmouth, Memorial Sloan Kettering Monmouth (All Protocol Activities), among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Middletown right now?
The largest active categories in Middletown are Cancer & tumors (255), Neurology & pain (2), HIV / STI (1). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
What is the address of Memorial Sloan Kettering Monmouth (All Protocol Activities)?
Memorial Sloan Kettering Monmouth (All Protocol Activities) is located at 480 RED HILL RD, MIDDLETOWN, NJ 07748-3052. Use the Google Maps link in the intro above to get directions.
How do I contact Memorial Sloan Kettering Monmouth (All Protocol Activities)?
You can reach Memorial Sloan Kettering Monmouth (All Protocol Activities) by phone at (212) 639-2000. For questions about a specific trial, use the study coordinator contact listed on the individual study record — click any trial title above to open it.